Alliance Pharma Share Discussion Threads

[davebowler] 11/9/2013 09:22

Alliance Pharma (AIM: APH), the speciality pharmaceutical company, has announced that sales for the six months ended 30 June 2013 were up 4% to £22.8m (H1 2012: £22.0m)

The company says that Hydromol�5533; continues to grow well and is now a £5m brand.

It is also launching MolluDab�5533;, a new treatment for molluscum contagiosum.

The half year profit before tax was up 29% to £6.8m (H1 2012: £5.3m) and the interim dividend is being increased by 10% to 0.303p per share (H1 2012: 0.275p)

Michael Gatenby, Alliance Pharma's chairman, said: "The strong start to 2013 augurs well for meeting full year expectations. We are energetically pursuing additional growth through further acquisitions, supported by strong UK and international teams, a good flow of opportunities, healthy cash flow and ample headroom in our funding facilities."

[2vdm] 11/9/2013 07:42

Woodcutter, I don't think it's less optimistic. All the management have done is to flag up where the company is heading and they have identified both the strengths and weaknesses as we move forward, and after a very credible first half. What gives me great confidence is such a clear unambiguous report, i.e. the BOD clearly know what they are doing. We are cash rich, profitable and continue to look for acquisitions. With ImmuCyst looking like it will be back in 2014, this is to my mind a nice small steady performer. I agree with you comments about the markets view and like you will buy on any dips.

[woodcutter] 11/9/2013 07:32

strong H1 results but less optimistic on the outlook. Difficult to predict how the market will react this morning. Some confidence in the full year given by the 10% increase in divi.

Watch and wait, any fall could be a decent buying opportunity.

Woody

[yorgi] 09/9/2013 14:01

Yes and pays a dividend as well :-)

[2vdm] 09/9/2013 13:57

fingers crossed yorgi. At least this is profitable unlike many AIM stocks

[yorgi] 09/9/2013 13:27

Steady buying today pushing the share price on again ahead of Wednesdays results.

The question is will there be any news of further acquisitions to add to our portfolio.

[mazarin] 30/8/2013 11:54

Found this comment relating to CULS program, reportedly quoted from John DAWSON at APH Mayfair Master Investor Presentation, thanks to Cisk's Post (No. 327)

"....CULS: I bemoaned the fact that the drip feed of CULS into the market depresses the price each time - John said he was not considering using these again to fund a deal (and indeed the recent enlarged banking facilities support this). I think he said they expire in October / November...."

So the above comment at least, suggests they should be finishing later this year.

[mazarin] 30/8/2013 11:01

It was my understanding from previous posts following a Company Presentation in May that APH BoD had decided no longer to continue with current round of CULs converstion transactions and that the program was due to finish. In my experience they generally have a negative impact on the share price that takes a little time to recover after the announcements. I believe CULs enables a Company to convert allotted shares into cash by way of unsecured loans. I thought the APH already have agreed Bank loan facilities in place, so wonder why BoD feel it necessary to continue with this process?

[yorgi] 22/8/2013 12:53

Buyers appear to be returning after some have taken a small profit this morning.

[yorgi] 21/8/2013 22:31

Having been introduced to APH at the Mi show in April and since then done my homework I made the decision to buy and added again close to recent lows......am I confident this has been a good buy.....Yes.

It has to increase sales and profitability to move forward and acquiring further products to their portfolio as well I agree but they have the funds for that and if history is anything to go buy then I have no doubt John Dawson will come up with the goods.

If it does not float your boat Pyemckay then I would give it a wide berth and move on to what does.

I was pleased to have discovered the company and Nigel Wray would appear to rate the business model as does Mark Slater along with others......

[pyemckay] 21/8/2013 21:48

i look at identical revenues over the last 2 years and next 2 years. Totally stagnent.It doesnt really float my boat.
I like real assets on the balance sheet but this has built up a lot of intangibles on the balance sheet that will need amortisised over time. Probably the norm for pharma.
With profits forecast to fall in 2014 This company needs to aquire to stand still.

[yorgi] 21/8/2013 21:24

Something like 70% of the shares are held by directors, investemnt institutions and Nigel Wray holds 13%.

[yorgi] 21/8/2013 21:18

Worth a look I feel Pyemckay....have you had a look at the major shareholders ?

[pyemckay] 21/8/2013 21:05

i need a pharma for diversification, will keep an eye on this regardless,

[yorgi] 21/8/2013 20:48

Yes but an acquisition or two would soon change that and with the companies history under John Dawson I would fully expect we will see new products soon to be added to our portfolio which will continue the growth.

I have no expectation of this being a mutibagger by any means but the business plan looks sound to me for continued steady growth along with a growing dividend and now of course ISAble.

[pyemckay] 21/8/2013 20:19

stagnent and slightly declining revenue and eps this year and next.

They have got to make aquisitions to grow which is risky. Good luck with this one guys unless there is something I have missed.

[norbert colon] 21/8/2013 18:51

I am certainly very happy with my 2 sub 32p buys at the end of July but am a long term holder and just glad to have had the chance to top-up - looking forward to it cracking 40p.

[yorgi] 21/8/2013 18:34

Mazarin,

I believe ADVFN took steps a few weeks or probably months ago now regarding non subscribed members from being able to post links when we were flooded by new posters day after day spamming the BB's with links to their website. So hence people like yourself are also affected.

On APH yes it has been having a good run as buyers taking advantage since the drop ti get in before the interims. I hope we will have news of a further acquisition but whether that is wisfuk thinking remains to be seen.

[mazarin] 21/8/2013 18:08

Thanks for uploading HR Yorgi, incidentally how did you manage to get ADVFN to allow you to give active link in your post? They always corrupt my web links to render them inactive when I try,unless its to one of their own sites.
APH has been my 'feel good factor' these last few days and provided 'a ray of shining light' amidst the all 'encircling gloom' of the wider market. Not a very technical description, but comforting all the same.

[yorgi] 21/8/2013 14:51

For those interested the latest Hardman Report :

[nw99] 21/8/2013 14:01

Chartist's dream here

[yorgi] 21/8/2013 12:31

We know from the RNS on 11th July that trading in the first half of the year is in line with management's expectations which should be confirmed very soon when the interims are released......so no big surprises coming there then. So providing the second half of the year follows that which we should get some hint of at the time of the interims I would expect. Then we should be looking at a EPS of something like 3.7p taken from Hardman's report. So based on that we should still have a fair upside from here......in my opinion north of 40p.

Then of course we should keep in mind :

"Alliance continues to explore a number of acquisition opportunities and remains confident of the outlook for the full year."

Whether the BOD will have anything for us on that front at the interims remains to be seen.

[yorgi] 21/8/2013 12:09

A slow start to the day but not many buys required to move the share price up again :-)

[yorgi] 20/8/2013 15:34

All very true Woody :-)

I notice another tick up before the close :-)

[woodcutter] 20/8/2013 15:33

yep i figure the uptrend will go until it hits potential resistance at 36/37p yorgi.

If we break through that with some good numbers or promising outlook statment on results day then we could see a move upwards beyond 38p and then it's in open water.

On top of that we've a decent yield too.